Can-Fite Biopharma (CF5.STU) Q1 2026 Earnings

26MarConfirmed
Q1 2026
-2.59
-1.72
-0.86
0

Details

Expected EPS
0
Actual EPS
-2.586204
Surprise EPS
-2.59
Surprise Percent
+∞%

Description

Can-Fite Biopharma (CF5.STU) has reported earnings of -2.586204 per share for Q1 2026.

0 Comments

Share your thoughts